chapter  5
9 Pages

2 Cost-effectiveness, cost–utility and cost-minimization analyses

An example of a cost-eectiveness analysis, based on the results of the Scandinavian Simvastatin Survival Study9 (see Case study 1.4.1 in Chapter 1.4) is shown in Case study 5.2.1.10 is shows the so-called ‘base case’ incremental cost-eectiveness ratio to be US$ 6768. e most signicant assumptions used in reaching this estimate are indicated in the case study 5.2.1 but include:

■ projecting life expectancy at the end of the trial (the mean follow-up in the trial was 5.4 years) to ten years;

T he

ra pe

ut ic

s, e

vi de

nc e

an d

de ci

si on

-m ak

in g

■ no additional costs for monitoring and o ce visits; ■ the discount rate.